Background and Objectives: This experiment evaluated the preventative influence of the
tomato-derived Esculeoside A (ESA) on diabetic cardiomyopathy in type 1 diabetes mellitus …

Several epidemiological studies have clearly identified diabetes mellitus (DM) as a major
risk factor for cognitive dysfunction, and it is going to be a major public health issue in the …

According to the latest statistics, more than 537 million people around the world struggle
with diabetes and its adverse consequences. As well as acute risks of hypo-or hyper …

Aim/hypothesis This study aimed to investigate the safety and efficacy of treatment with
allogeneic Wharton's jelly-derived mesenchymal stromal cells (MSCs) in recent-onset type 1 …

The worldwide incidence of type 1 diabetes mellitus (T1DM) has increased in recent
decades. The reasons behind this phenomenon are not yet fully understood. Early life …

Incretin-based therapies, in particular glucagon-like peptide-1 (GLP-1) receptor agonists,
have been evaluated in other forms of diabetes, but randomised controlled trials are mainly …

Abstract Tyrosine kinase 2 (TYK2), a member of the JAK family, has attracted attention as a
potential therapeutic target for autoimmune diseases. However, the role of TYK2 in CD8+ T …

Diabetic nephropathy (DN) is a major complication of type 1 diabetes mellitus, and
hyperglycemia and hypertension are the main risk factors for the development of DN. N …

Type 1 Diabetes (T1D) is an autoimmune destruction of pancreatic beta cells. The
development of the Edmonton Protocol for islet transplantation in 2000 revolutionized T1D …

Abstract Background and Aims Patients with some chronic liver diseases have increased
risk of diabetes. Whether this is also the case for patients with autoimmune liver diseases is …